Exploring the Potential of Cell Therapy Technologies Market in the Healthcare Industry – Exclusive Report by MarketsandMarkets™
Exploring the Potential of Cell Therapy Technologies Market in the Healthcare Industry – Exclusive Report by MarketsandMarkets™
Cell Therapy Technologies Market is projected to grow from USD 4.0 billion in 2022 to USD 8.0 billion by 2027, at a CAGR of 14.6% from 2022 to 2027

Cell therapy technologies are one of the most innovative and rapidly growing areas of modern medicine. Cell therapies involve the development and use of living cells, such as stem cells, for the treatment of diseases and injuries. These therapies have the potential to revolutionize the way we treat disease and injury, and the global cell therapy technologies market is expected to expand rapidly over the coming years.

Cell therapies offer a wide range of potential medical benefits, such as regenerative medicine, gene therapy, and tissue engineering. In regenerative medicine, stem cells are used to replace or repair damaged or diseased cells, tissues, or organs. Gene therapy involves the introduction of genetic material into cells to correct genetic defects. Tissue engineering involves the use of living cells to regenerate and replace damaged or diseased tissue.

Download PDF Brochure:

The global cell therapy technologies market is driven by the increasing demand for cell therapies for the treatment of various diseases and injuries. The growing prevalence of chronic diseases, such as cancer and cardiovascular disease, is driving the demand for cell therapies. Additionally, the increasing acceptance of cell therapies among healthcare providers and the rising investments in the development of cell therapies are expected to drive the growth of the cell therapy technologies market.

Key Highlights of the Cell Therapy Technologies Market growth Report:

·         Market introduction, including market development and status.

·         Analysis and trends in manufacturing technology.

·         Market analysis, including company and country status and competition.

·         According to market estimates, the following business segments are essential.

·         Future growth rate estimation, as well as valuation of each region.

·         A geographical analysis of the product/service consumption in each region.

·         Forecast market analysis by segment.

Key Market Players

The major players operating in the global cell therapy technologies market include Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Lonza Group (Switzerland), Sartorius AG (Germany), Terumo BCT (US), Becton, Dickinson and Company (US), Fresenius SE & Co. KGaA (Germany), Avantor, Inc. (US), Bio-Techne Corporation (US), Corning Incorporated (US), FUJIFILM Irvine Scientific (US), MaxCyte Inc. (US), Werum IT Solutions GmbH (Germany), RoosterBio Inc. (US), SIRION Biotech GmbH (Germany), TrakCel (UK), L7 Informatics, Inc. (US), Miltenyi Biotec GmbH (Germany), STEMCELL Technologies (Canada), GPI Iberia (Spain), MAK-SYSTEM (US), OrganaBio, LLC (US), IxCells Biotechnology (China), and Wilson Wolf Manufacturing Corporation (US). These companies are investing heavily in the development of cell therapies and are also partnering with other companies to expand their product portfolios. Additionally, they are focusing on collaborations with academic institutions and research centers to develop innovative products.

Thermo Fisher Scientific offers a complete and integrated portfolio of solutions and services for clinical science, laboratory research, and analysis. It operates in four business segments—Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. Its Life Sciences Solutions segment offers a wide range of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs and vaccines, as well as the diagnosis of diseases.

The global cell therapy technologies market is expected to witness strong growth over the coming years. The growing acceptance of cell therapies and the increasing investments in the development of cell therapies are the major factors driving the growth of the market. Additionally, the rising prevalence of chronic diseases and the increasing demand for cell therapies for the treatment of various diseases and injuries are expected to further fuel the growth of the market.

Request Sample Pages:

This report categorizes the cell therapy technologies market into the following segments and subsegments

By Product

  • Media, Sera, and Reagents
  • Cell Engineering Products
  • Cell Culture Vessels
  • Cell Therapy Equipment
  • Cell Processing Equipment
  • Single-use Equipment
  • Other Equipment
  • Systems and Software
  • Other Products

By Process

  • Cell Processing
  • Cell Preservation, Distribution, and Handling
  • Process Monitoring and Quality Control

By Cell Type

  • T-cells
  • Stem Cells
  • Other Cells

By End User

  • Biopharmaceutical and Biotechnology Companies
  • CROs and CMOs
  • Research Institutes and Cell Banks

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Recent Developments

  • Thermo Fisher Scientific launched the first T-cell medium designed specifically for allogeneic cell therapy workflows.
  • Danaher acquired the Biopharma business from General Electric Company's Life Sciences division. The acquisition has led to the formation of a new business named Cytiva, a standalone operating company within Danaher's Life Sciences segment.

Get 10% Free Customization on this Report:

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.